Skip to main content

09-10-2020 | Cancer | News

New-onset type 2 diabetes accompanied by weight loss may point to pancreatic cancer risk

Author: Alba Ruzafa


medwireNews: Type 2 diabetes and weight loss are independently associated with an increased risk for pancreatic cancer, and this risk is further elevated when weight loss occurs together with recent-onset diabetes, according to results from a cohort study.

Chen Yuan, from the Dana-Farber Cancer Institute in Boston, Massachusetts, USA, and fellow researchers analyzed data from 112,818 women, with a mean age of 59.4 years, and 46,207 men, with a mean age of 64.7 years, obtained from the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS), respectively.

The team identified a total of 1116 incident cases of pancreatic cancer, giving an incidence rate of 25 per 100,000 person–years during 4.5 million person–years of follow-up.

In all, 937 individuals with known diabetes status developed pancreatic cancer; 14.4% of these people had long-standing (>4 years) diabetes, while 7.2% had recent-onset (≤4 years) diabetes. Yuan and colleagues report that individuals with diabetes had a significantly higher risk for pancreatic cancer than those without diabetes, with age-adjusted hazard ratios (HRs) of 2.97 for those with recent-onset diabetes and 2.16 for those with long-standing diabetes. They add that “these elevated cancer risks were present for individuals regardless of their BMI.”

There was also a significant association between recent weight loss and pancreatic cancer risk, with age-adjusted HRs of 1.25, 1.33, and 1.92 for the groups who had lost 1–4 lb (0.45–1.81 kg), 5–8-lb (2.27–3.63 kg), and more than 8 lb (3.63 kg), respectively, over the previous 2 years when compared with individuals in the no weight loss group.

Therefore, “diabetes and recent weight loss were each independently associated with a moderate increase in the risk for pancreatic cancer,” write Yuan et al in JAMA Oncology.

However, when these variables were analyzed together, individuals with recent-onset diabetes combined with weight loss of 1–8 lb or more than 8 lb had a “substantially” higher incidence of pancreatic cancer, with age-adjusted HRs of 3.61 and 6.75, respectively, compared with individuals with neither exposure.

On the other hand, for people with long-standing diabetes and weight loss, the team says that the increased risk for pancreatic cancer was “less pronounced,” with HRs of 2.90 for individuals with a loss of 1–8 lb, and 2.80 for the group with a loss of more than 8 lb. These results were consistent when the NHS and HPFS cohorts were analyzed separately.

The researchers also carried out stratified analyses “[t]o further define groups with a high risk for pancreatic cancer” among individuals with recent-onset diabetes and weight loss, finding that people aged 70 years or older, those with a BMI of less than 25 kg/m2 before weight loss, and those with a low likelihood of intentional weight loss as indicated by changes in physical activity and diet had “particularly high” incidence rates of pancreatic cancer.

The team concludes that “recent-onset diabetes accompanied by weight loss [...] may represent a high-risk group in the general population for whom early detection strategies would be advantageous.”

JAMA Oncol 2020; doi:10.1001/jamaoncol.2020.2948

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2020 Springer Healthcare Ltd, part of the Springer Nature Group


Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »